Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

Monthly Archives: April 2017

NJIT Hosts Ribbon Cutting of Renovated Central King Building

Newark, NJ, April 22, 2017 — Once home to thousands of Newark Central High School students, the Central King Building at New Jersey Institute of Technology (NJIT) today exemplifies intelligent, creative and economically impactful urban redevelopment that serves NJIT students, industry and the local community.

On April 13, 2017, more than 200 students, alumni, faculty, staff and friends of NJIT witnessed the official ribbon cutting of the renovated Central King Building, part of a campus transformation designed to enhance the student experience and solidify NJIT’s position going forward as one of the nation’s leading public polytechnic universities. Continue reading

Opinion: Rutgers President Robert Barchi: ‘March for Science and a Better America’

Robert Barchi, M.D., Ph.D.

New Brunswick, NJ, April 21, 2017On the eve of tomorrow’s March for Science in Washington and around the world, Rutgers University President Robert L. Barchi writes in USA Today:

Scientists and other concerned citizens will gather in Washington and hundreds of other cities this weekend to march for science.

From astrophysicists, biologists, chemistry teachers and computer science students to lab technicians, surgeons, oceanographers and nurses, these advocates are united not by party or ideology but by a respect for research and the power of evidence-based decision-making.

The marchers want what all of us want: good health, clean water and fresh air, a strong economy and safe communities. Continue reading

Opinion: FDU President Christopher A. Capuano: ‘How to Stop New Jersey’s Brain Drain’

Dr. Christopher A. Capuano

Madison, NJ, April 21, 2017Fairleigh Dickinson University President , Ph.D., published the following op-ed in The Star-Ledger on April 14:

For decades, New Jersey has been one of the highest exporters of college students. Students go to college in other states for lots of reasons.

One reason is that New Jersey is a small state and many choices are located within close proximity to its borders — in Pennsylvania, New York, Connecticut and Delaware. Continue reading

Rutgers’ Office of Federal Relations Advocates for Science Year-Round

Francine Newsome Pfeiffer

Washington, DC, April 21, 2017 — As people across the nation prepare to take to the streets of Washington, D.C., and more than 400 cities to champion the value of science on April 22 (Earth Day), Rutgers’ Office of Federal Relations has a year-round mission to advocate for scientific research.

The Office of Federal Relations, located just steps away from the Capitol Building at 400 North Capitol Street NW in Washington, works closely with administrators, faculty, staff and students throughout Rutgers to build relationships with key federal policymakers that will help advance the important scientific work underway across the university.

The office works closely with the New Jersey congressional delegation and national associations of higher education to be a voice for Rutgers and for science on a national level. Continue reading

Non-Adherence: The Cost of Not Taking Your Medicine

New York, NY, April 21, 2017 — Jane E. Brody writes in her Well column in The New York Times that there is an out-of-control epidemic in the United States that costs more and affects more people than any disease Americans currently worry about. It’s called nonadherence to prescribed medications, and it is — potentially, at least — 100 percent preventable by the very individuals it afflicts.

The numbers are staggering. “Studies have consistently shown that 20 percent to 30 percent of medication prescriptions are never filled, and that approximately 50 percent of medications for chronic disease are not taken as prescribed,” according to a review in Annals of Internal Medicine. Continue reading

March for Science Partners Work to Put a Human Face on Science; Event Set for April 22 in Washington

Washington, DC, April 20, 2017 — Anne Q. Hoy reports for the American Association for the Advancement of Science (AAAS) that scientific organizations partnering with the March for Science are stressing the need for scientists to connect more directly with policymakers and the public both now and in the future to build support for science and explain its value for society.

More than 220 organizations, representing many leading scientific organizations and academic research powerhouses, are supporting what has grown into a global event with more than 500 satellite marches well beyond the National Mall in Washington on April 22, from Greenland and Ghana to India and Chile. Continue reading

Trump Administration Seeks to Hike Life Sciences Industry’s FDA User Fees Paid to Help Review, Approve Medical Advancements

Washington, DC, April 20, 2017 — Thomas M. Burton reported in The Wall Street Journal that a bipartisan bill in Congress calls for sharp increases in user fees paid by medical industries to the Food and Drug Administration (FDA) to bear the cost of reviewing brand-name and generic drugs, medical devices and a type of generics called biosimilars.

The total base fees for prescription drugs to be collected for fiscal year 2018 under the legislation would be about $878.8 million, up 22% from the current fiscal year’s amount of $718.7 million, according to congressional aides.

The payments from industry have previously accounted for 70% of the FDA’s brand-name drug review budget, 36% of the medical device review budget, 75% of the budget for generic drug reviews and 29% of that for biosimilars, which mimic complex biological drugs. Continue reading

Rutgers Medical Students’ Promise Clinic Offers Care for Area Poor and Homeless

Stephanie Oh, a Rutgers medical student and student director of the Promise Clinic

New Brunswick, NJ, April 20, 2017 — Stephanie Oh knows what it’s like to live at the poverty line.  After graduating college with a degree in bioengineering, she volunteered for AmeriCorps and subsisted on food stamps.

“This experience made me better understand the struggles people face trying to live healthy on a limited income,” says Oh, now a medical and doctoral student in neuroscience at Rutgers Robert Wood Johnson Medical School.

Today, Oh puts her knowledge of medicine and indigent and homeless populations into practice as the student director of the Promise Clinic, an initiative that provides primary health care for clients of Elijah’s Promise Community Kitchen in New Brunswick. Continue reading

Rowan College at Burlington County Student Anna Wilson Earns Top Female Student in Statewide Mathematics Competition

(Clockwise, starting from left front) Rowan College students Tommy O’Shaunessy, Anna Wilson, Cheyanne Kelly, and Pingping Song

Mount Laurel, NJ, April 20, 2017 — A Rowan College at Burlington County (RCBC) student recently earned distinction as the Top Female Student in a statewide mathematics competition featuring top math students from two- and four-year colleges in the region.

Anna Wilson, 18, of Shamong, tied for ninth place overall out of 77 students, making her the first RCBC student to place in the top 10 at the New Jersey Undergraduate Mathematics Competition, which also earned her a tie for the Top Female Student at the competition.

Wilson was among eight students, also including Pingping Song, Tommy O’Shaughnessy, Caitlin Proto, Jonathan Zablin, Cheyanne Kelly, Bryan Bugyi and Liam Doherty, who participated in the competition at The College of New Jersey in Ewing after months of preparation. Continue reading

I-ACT for Children Launches to Promote Innovative Medicines Development for Young Patients in Need

Washington, DC, April 19, 2017 — Lucy Vereshchagina reports on PhRMA’s Catalyst blog that, in an exciting step forward to support research and development of innovative new medicines and devices for pediatric patients, the Critical Path Institute (C-Path) announced the launch of a new nonprofit to address challenges in bringing new therapies to children in need.

Called the Institute for Advanced Clinical Trials for Children (I-ACT for Children), this new organization will seek to foster public-private collaboration in finding solutions to barriers to pediatric medicines development as well as improving the pediatric clinical trials process.

Specifically, it will work to optimize pediatric study designs, protocols, best practices, training and engagement of patients and parents to advance clinical trials to improve children’s health. Continue reading